Evidence map›Paper›PMID 28266553›Full record

ArticleScientific reports2017

Experimental Evaluation of Kidney Regeneration by Organ Scaffold Recellularization.

Andrea Remuzzi, Marina Figliuzzi, Barbara Bonandrini, Sara Silvani, Nadia Azzollini, Roberta Nossa, Ariela Benigni, Giuseppe Remuzzi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Decellularized rat tubules for tissue engineering.Translational andrology and urology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Current status and future prospects of decellularized kidney tissue.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Kidney regeneration approaches for translation.World journal of urology · 2020
    Review
  17. PKHCells · 2020
    Article
  18. Recapitulating kidney development: Progress and challenges.Seminars in cell & developmental biology · 2019
    Review
  19. Article
  20. Mesenchymal Stem Cells-Potential Applications in Kidney Diseases.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andrea RemuzziIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Marina FigliuzziIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Barbara BonandriniIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Sara SilvaniIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Nadia AzzolliniIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Roberta NossaIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Ariela BenigniIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Giuseppe RemuzziIRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori Via Stezzano 87 - 24126 Bergamo, Italy.
Mario Negri Institute for Pharmacological Research · ITOspedale Papa Giovanni XXIII · IT

Funding

European Research Council 268632
6 · The paper itself

Abstract

The rising number of patients needing renal replacement therapy, alongside the significant clinical and economic limitations of current therapies, creates an imperative need for new strategies to treat kidney diseases. Kidney bioengineering through the production of acellular scaffolds and recellularization with stem cells is one potential strategy. While protocols for obtaining organ scaffolds have been developed successfully, scaffold recellularization is more challenging. We evaluated the potential of in vivo and in vitro kidney scaffold recellularization procedures. Our results show that acellular scaffolds implanted in rats cannot be repopulated with host cells, and in vitro recellularization is necessary. However, we obtained very limited and inconsistent cell seeding when using different infusion protocols, regardless of injection site. We also obtained experimental and theoretical data indicating that uniform cell delivery into the kidney scaffolds cannot be obtained using these infusion protocols, due to the permeability of the extracellular matrix of the scaffold. Our results highlight the major physical barriers that limit in vitro recellularization of acellular kidney scaffolds and the obstacles that must be investigated to effectively advance this strategy for regenerative medicine.

Indexed as

KidneyRegenerationTissue EngineeringTissue ScaffoldsAnimalsExtracellular MatrixMaleRatsRegenerative Medicine

Identifiers

PMID28266553
PMCPMC5339865
OpenAlexW2593174409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.